<DOC>
	<DOCNO>NCT00457002</DOCNO>
	<brief_summary>The purpose study learn apixaban prevent blood clot leg ( deep vein thrombosis [ DVT ] ) lung ( pulmonary embolism [ PE ] ) sometimes occur within patient hospitalize acute medical illness , learn apixaban compare enoxaparin ( Lovenox® ) prevent clot . The safety apixaban also study .</brief_summary>
	<brief_title>Study Apixaban Prevention Thrombosis-related Events Patients With Acute Medical Illness</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>men nonpregnant , nonbreastfeeding woman 40 year old hospitalize congestive heart failure acute respiratory failure infection ( without septic shock ) acute rheumatic disorder inflammatory bowel disease patient venous thromboembolism ( VTE ) active bleeding high risk bleed unable take oral medication disease require ongoing treatment anticoagulant antiplatelets aspirin dose ≤ 165 mg/day .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Prevention deep vein thrombosis pulmonary embolism acutely ill hospitalize patient</keyword>
</DOC>